In cases of fungal infection of the bloodstream, rapid species identification is crucial to provide adapted therapy and thereby ameliorate patient outcome. Currently, the commercial Sepsityper kit and the sodium-dodecyl sulfate (SDS) method coupled with MALDI-TOF mass spectrometry are the most commonly reported lysis protocols for direct identification of fungi from positive blood culture vials. However, the performance of these two protocols has never been compared on clinical samples. Accordingly, we performed a two-step survey on two distinct panels of clinical positive blood culture vials to identify the most efficient protocol, establish an appropriate log score (LS) cut-off, and validate the best method. We first compared the performance of the Sepsityper and the SDS protocols on 71 clinical samples. For 69 monomicrobial samples, mass spectrometry LS values were significantly higher with the SDS protocol than with the Sepsityper method (P < .0001), especially when the best score of four deposited spots was considered. Next, we established the LS cut-off for accurate identification at 1.7, based on specimen DNA sequence data. Using this LS cut-off, 66 (95.6%) and 46 (66.6%) isolates were correctly identified at the species level with the SDS and the Sepsityper protocols, respectively. In the second arm of the survey, we validated the SDS protocol on an additional panel of 94 clinical samples. Ninety-two (98.9%) of 93 monomicrobial samples were correctly identified at the species level (median LS = 2.061). Overall, our data suggest that the SDS method yields more accurate species identification of yeasts, than the Sepsityper protocol.
Introduction
Bloodstream infections represent a major medical issue, especially in intensive care units. An increasing number of reports have shown that fungemia, primarily candidemia, are associated with high mortality rates. 1, 2 Candidemia is primarily due to Candida albicans and C. glabrata, although many other fungal species can be encountered in such infections. 1, 2 As drug susceptibility is species dependent, 3 rapid species identification is crucial for proper treatment. Indeed, while C. albicans is usually susceptible to fluconazole, C. glabrata isolates often exhibit resistance patterns that require expensive antifungal therapy. Currently, species identification is primarily performed on colonies grown on solid media. Hence, 24-48 hours are generally required to obtain sufficient colony isolation for species identification, a delay that could have a deleterious effect on patient outcome, 4, 5 To shorten this delay, several methods involving direct analysis on positive blood cultures have been proposed. These techniques, based on speciesspecific PCR, non-specific PCR followed by sequencing or in situ hybridization fluorescence, [6] [7] [8] are either costly or time-consuming and thus hardly feasible in the routine clinical setting. Alternatively, Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) technology has been recently applied for direct identification of microorganisms in positive blood culture vials. 9 Performing such direct identification requires blood culture pre-treatment to eliminate host cells and proteins. Various techniques are available for this critical step, including both commercial and in-house protocols based on either differential centrifugation or lysis using agents, such as Tween, saponin, Brij97 and sodium dodecyl sulfate (SDS). [10] [11] [12] [13] [14] Among the available protocols, the Sepsityper kit commercialized by Bruker Daltonik and the in-house SDS-based protocol are the most widely proposed methods in the medical literature. 8, 9, [15] [16] [17] Most of these assays were conducted using the Bruker Daltonik system except one which tested the SDS protocol using the Vitek-MS system of bioMérieux. 17 Unfortunately, studies comparing the Sepsityper kit with the SDS-based protocol are scarce, as each approach has often been tested individually, using different study designs, algorithms and thresholds to accept or reject a given result. Indeed, most of these studies established species identification log scores (LS) at 1.7, 1.6, 1.5, or even lower. 15, [18] [19] [20] For other studies applying low LS values, additional criteria were usually included (e.g., in cases for which the same species was proposed in the first two or three identifications or a significant difference in the LS was noted between the first and second species suggested by the MALDI Biotyper software). 21, 22 We only identified one survey simultaneously assessing the performance of the Sepsityper kit, the SDS-based protocol, and other lysis agents. 23 However, this assessment was carried out exclusively on spiked blood cultures and not clinical cultures. Therefore, we compared the performance of the Sepsityper kit and SDS-based method in the identification of yeasts from blood cultures. This prospective survey was implemented in a two-step fashion. First, we used a panel of positive clinical blood cultures to compare the two approaches and determine the most appropriate decision algorithm and threshold for direct identification of yeast species. Second, we used a distinct panel of positive clinical blood cultures to validate the findings and assess the performance of the better-performing protocol based on the results of the first step.
Materials and methods

Clinical samples
The The Sepsityper kit lysis protocol was carried out according to the manufacturer's recommendations. Briefly, 200 μl of lysis buffer was added to 1 ml of positive blood culture and vortexed for 10 s. After a centrifugation step of 13 000 g for 1 min, the supernatant was removed and the pellet was resuspended in 1 ml of wash buffer prior to a second centrifugation step of 13 000 g for 1 min. The pellet was then resuspended in a mixture of 900 μl absolute ethanol (Carlo Erba SDS, Val de Reuil, France) and 300 μl sterile water (Water HPLC, Prolabo BDH, Fontenay-sous-Bois, France).
SDS lysis-based protocol
To perform the SDS lysis-based technique, 1.8 ml of positive blood culture was transferred into a 2-ml microtube. After a centrifugation step of 13 000 g for 2 min, the supernatant was removed, the pellet was resuspended in 1.8 ml of sterile distilled water and the microtube was centrifuged at 13 000 g for 2 min. Next, the supernatant was removed, and the pellet was resuspended in 1.8 ml of 0.1% SDS in sterile distilled water and incubated for 10 min. After another wash step, the pellet was resuspended in a mixture of 900 μl ethanol and 300 μl sterile water.
Protein extraction and mass spectrometry identification
Protein extraction was performed identically for the two protocols. After a centrifugation step of 13 000 g for 5 min, the supernatant was removed, and the pellet was air-dried at room temperature for 10 min. Next, depending on the pellet quantity, the pellet was resuspended in 10-20 μl of 70% formic acid (Sigma-Aldrich, Lyon, France) and incubated for 5 min. The same volume of 100% acetonitrile (Prolabo BDH) was then added to the sample. The mixture was incubated for 5 min and then centrifuged for 2 min at 13 000 g. Subsequently, 1 μl of the supernatant was spotted in quadruplicate onto polished steel targets and air-dried at room temperature. Each spot was then overlaid with 1 μl of matrix solution (a saturated solution of α-Cyano-4-hydroxycinnamic acid (CHCA) (Sigma-Aldrich Chimie, L'Isle d'Abeau Chesnes, France) in 50% acetonitril and 2.5% trifluoroacetic acid (Life Technologies, Carlsbad, CA, USA) and air-dried at room temperature. The samples were analysed using a Microflex LT TM Instrument (Bruker Daltonics GmbH, Bremen, Germany). The resulting spectra were analyzed using MALDI Biotyper v3.0 software (Bruker Daltonics GmbH), which contains the 4111-entry reference version of the Bruker Daltonics database.
DNA sequencing identification from colony subcultures
Three to five drops of positive sample were inoculated onto Sabouraud gentamicin chloramphenicol (Oxoid, Dardilly, France) and CHROMagar (Becton Dickinson GmbH, Heidelberg, Germany) media. Once colony growth was apparent, generally between 24 and 48 h, we performed species identification via DNA sequence analysis. DNA extraction was performed using a NucliSENS easyMag system. 24 The sequencing reactions were performed on PCR amplification products of the internal transcribed spacer 2 (ITS2) region of the ribosomal RNA gene and the D1-D2 variable region of the 28S ribosomal DNA gene. 25, 26 Sequence analysis was performed using an ABI3130 × l Genetic Analyzer (Applied Biosystems, Villebon Sur Yvette, France), and the derived sequences were verified against the NCBI database using the BLAST program. 27 The identification was accepted when the queried sequence shared at least 99% homology with a unique species in the NCBI nucleotide collection general database. To ensure for the reliability of the results, the sequences were further verified against type material reference sequences.
Evaluation of the best lysis protocol
The second arm of our study aimed to assess the performance of the method (including extraction protocol, algorithm and threshold) that yielded the best results on a distinct set of clinical positive blood cultures. For this purpose, we established two evaluation criteria: (1) the proportion of positive blood cultures for which the conditions of identification were achieved and (2) the accuracy of species identification based on the positive predictive value. We preferred these validation criteria over sensitivity and specificity, as they were more appropriate for the two-step approach applied for biological diagnosis: we first accepted or rejected a result depending on the acceptance criteria and then transmitted this result to the physician. The second panel of tested samples corresponded to 94 positive blood cultures. The experiments were performed in the Mycology Department of La Timone Hospital in Marseille (n = 29) and the Mycology Department of L'Archet Hospital in Nice (n = 65). In Nice, species identification was performed on aerobic positive blood cultures incubated in a BacT/ALERT R 3D automated microbial detection system (bioMérieux, Marcy l´Etoile France). Additionally, different CHCA matrix (Bruker IVD Matrix HCCA-portioned, Bremen, Germany) and organic solvent (Acetonitrile 50%, Water 47.5%, and Trifluoroacetic acid 2.5%, SigmaAldrich Chemie, GmbH, Germany) were used in Nice. All Figure 1 . MALDI-TOF MS log scores obtained using the Sepsityper kit and the SDS protocol, considering the first or the best spot data. The SDS-Best of 4 spots Log scores were significantly higher than those of the three other approaches (P < 0.0001).
identifications were further confirmed or rejected via DNA sequence analysis of colonies grown on Sabouraud gentamicin chloramphenicol and CHROMagar media.
Statistical analyses
The Sepsityper extraction and result of a single spot (STKSingle spot), the Sepsityper extraction and the best result of four deposited spots (STK-Best of 4 spots), the SDS-Single spot, and the SDS-Best of 4 spots were compared using the Wilcoxon test for paired samples with STATVIEW software, and statistical significance was set at P < .05.
Results
Seventy-one yeast isolates were collected and sequenced from the 71 blood vials used for the first step of the study. Sixty-nine yeast isolates corresponded to monomicrobial infections that were identified via DNA sequencing as follows: 28 C. albicans (40.58%), 16 C. glabrata (23.18%), 10 C. parapsilosis (14.49%), three C. tropicalis (4.34%), three C. dubliniensis (4.34%), two C. orthopsilosis (2.89%), two C. lusitaniae (2.89%), two Rhodotorula (R.) mucilaginosa (2.89%), two Mucor circinelloides-f-janssenii (2.89%), and one Pichia caribbica (1.44%). Two additional C. albicans isolates were collected from mixed infections, one involving Pseudomonas aeruginosa and the other involving Enterococcus faecalis. The two mixed infections were immediately detected via microscopic examination of the corresponding samples. However, only P. aeruginosa and E. faecalis (LS > 2; whatever the protocol used) were identified via MALDI-TOF identification, whereas a subculture step was necessary to correctly identify the yeasts. As the MALDI Biotyper software is not tailored to identify mixed cultures, these two samples were removed from the subsequent analyses. Regarding MALDI-TOF direct identification from the 69 monomicrobial-positive blood cultures, we compared the LS obtained using the four tested approaches: (1) Sepsityper extraction and result of a single spot (STK-Single spot); (2) Sepsityper extraction and the best result of four deposited spots (STK-Best of 4 spots); (3) SDS-based extraction and result of a single spot (SDS-Single spot); and (4) SDS extraction and the best result of four deposited spots (SDS-Best of 4 spots). As shown in Figure 1 , SDS-Best of 4 spots yielded significantly higher LS values than the other three approaches (P < .0001) (Figure 1) .
We then compared the MALDI-TOF scores with sequence results to establish a threshold for the 69 monomicrobial-positive blood cultures. Table 1 summarizes the results of species identification in regards to the extraction protocol considering different LS cut-off.
The highest scores associated with misidentification were as follows: 1.474 for the STK-Single spot, 1.483 for the STK-Best of 4 spots, 1.302 for the SDS-Single spot, and 1.509 for the SDS-Best of 4 spots. We found that we could Table 2 . Correct identification with a log score >1.7 in regards to the species and protocol for the monomicrobial positive blood cultures. correctly identify fungal species by (1) using the SDS protocol, (2) depositing four spots, (3) taking the best among the four LS values and (4) accepting the result if the LS reached 1.7. Only two Mucor circinelloides f. janssenii and one Pichia caribbica samples did not reach the acceptance LS cut-off. In addition to these two species, the SDS-Single spot technique failed to identify one R. mucilaginosa and one C. orthopsilosis. Regarding the STK protocol, we failed to obtain scores >1.7 for nine C. glabrata, two C. parapsilosis, one R. mucilaginosa, three C. dubliniensis, one C. tropicalis and two C. orthopsilosis. Furthermore, the STK protocol yielded scores <1.7 for five C. albicans considering the single spot and for two C. albicans considering the best spot (Table 2) . During the second arm of the survey, 94 positive blood cultures, including 93 monomicrobial blood cultures, were analyzed using the SDS-Best of four spots approach. The identifications of the organisms were verified based on the match of the spectra to the Bruker database. Among the 93 monomicrobial-positive blood cultures, LS >1.7 was obtained in 92 cases (98.9%) (Median = 2.061). All identified species (i.e., 37 C. albicans, 18 C. glabrata, three C. krusei, four C. lusitaniae, 17 C. parapsilosis, six C. tropicalis and seven Magnusiomyces capitatus) were further confirmed via DNA sequence analysis.
The only monomicrobial-positive culture that yielded an LS under 1.7 (LS = 1.627) was identified as C. albicans via DNA sequencing. Finally, we succeeded to identify one C. parapsilosis sample (LS > 2) but failed to identify the associated C. glabrata in the only mixed infection of our second panel.
Discussion
In cases of invasive fungal infection, it is critical to rapidly identify the causative agent at the species level and is of a great importance as antifungal susceptibility is speciesdependent and antifungal susceptibility tests require at least 48 h once the blood culture is determined positive. In this survey, we assessed the identification of yeasts directly from positive blood culture flasks by comparing two techniques: the Sepsityper kit and the SDS-based protocol. Overall, our study showed that the SDS protocol yielded more accurate identification results. This is congruent with the study by Bidart et al. in which the two protocols were compared using spiked blood cultures and the SDS extraction protocol yielded better species identification. 23 Our results obtained using the Sepsityper kit are also in accordance with most other surveys that highlighted the difficulty of accurately identifying yeasts at the species level. 19, 21, 22, [28] [29] [30] Nevertheless, the Sepsityper kit enables more reliable species identification of bacteria, especially Gram-negative species. 19, 31 In most surveys performed on bacteria or yeasts, lowering the LS cut-off, which is often carried out in an arbitrary manner, generally enhances the correct identification ratio. 15, [18] [19] [20] [21] [22] 28 In fact, the manufacturer (Bruker Daltonics GmbH)-recommended LS thresholds for species and genus identification, >2 and [1.7-2], respectively, were established for pure colony-grown culture and appear too stringent for direct identification from a complex and heterogeneous culture medium. 32, 33 Indeed, positive blood cultures contain host cells and proteins as well as medium elements, which could generate additional peaks in the microorganism spectrum and thereby hamper proper species identification. Hence, the complexity of blood culture media renders it more difficult to obtain high LS. Furthermore, our results suggest that lowering the LS cut-off would not impair correct species identification. These findings need to be confirmed in a larger panel of isolates that includes species not investigated in this survey. We accepted a 1.7-LS cut-off for our survey, as we did not observe a single species misidentification above an LS of 1.509, regardless of the protocol used. In fact, the cut-off score was fixed at 1.7 considering the relatively small number of samples that yielded scores between 1.509 and 1.7. Nevertheless, we were able to obtain 1.7 or higher in most cases. We acknowledge that there is no perfect threshold and that misidentification may occur even with score above 1.7. Therefore, when obtaining LS >1.7, we consider the result reliable enough to provide to the clinicians. However, taken the limited number of species tested in our survey it is reasonable to inform them that this result must be confirmed and completed with subculture on specific medium. The species is also tested for antifungal susceptibility.
It is important to highlight that failing to completely remove host proteins often leads to poor identification scores, as demonstrated in protocols in which a lysis step was not included. 34, 35 Thus, we performed an additional lysis step in cases for which a clean white pellet (upon macroscopic examination) was not obtained from the first lysis step. This process, which takes an additional 10 min, may also explain the superior results obtained with the SDS protocol. Correct identification and LS were also improved by depositing four spots instead of one without generating any loss of time. In some cases, depositing only one spot yielded a poor identification due to inadequate pipetting or impurities present on the plate. The spectra were obtained by the MALDI Biotyper and the identification scores were obtained by comparing our spectra with the Bruker MALDI Biotyper 3.0 Database. Although we have established an improved inhouse database obtained from pure cultured isolates, 36 we used this approach to reduce bias associated with the reference database, in case the same protocol should be performed elsewhere. Accordingly, our results demonstrate that this SDS protocol can be performed in laboratories in possession of the Bruker database without any additional references. When we compared our spectra to our in-house reference database, we obtained even better scores. Interestingly, we obtained scores >1.7 for the two Mucor circinelloides f. janssenii and Pichia caribbicca samples that failed correct identification using the Bruker database, reaching 100% correct identifications with the SDS best spot protocol for our first panel of positive blood cultures. In our second panel, the fact that the majority of the identifications (68.8%) were performed on aerobic blood cultures with different matrix preparation did not affect the results. Indeed, all yeasts could be identified with the exception of one C. albicans sample that did not reach the threshold. These findings indicate that reliable identification results can be obtained with different material and that the SDS protocol is adaptable.
Finally, the main drawback of our approach is that only one species can be identified in cases of mixed infections.
We found only three mixed infections, involving two distinct pathogens, and each time, only one of them could be identified directly from the blood vial. Mixed bacteria/yeast infections are relatively easy to detect by performing Gram staining on the blood culture. However, mixed infections of more than one yeast species are more complicated to determine, as demonstrated in our second panel.
It is generally admitted that mixed infections represent one major limitation of MALDI-TOF-based identification. 10, 15, 16, 21, 31, 37 Mixed infections still necessitate prior growth in culture medium to obtain an accurate identification. Hence, in our department, yeast-positive blood cultures are systematically subcultured on CHROMagar medium, even when good identification scores have been obtained by applying the direct identification protocol. Overall, this study demonstrates that SDS protocol outperformed the Sepsityper kit in accurate yeast identification from positive blood cultures. Furthermore, as this inexpensive protocol enables rapid (only 75 min) species identification, disease management and patient outcome are significantly improved.
